168 related articles for article (PubMed ID: 22948256)
1. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
Berry WL; Shin S; Lightfoot SA; Janknecht R
Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
[TBL] [Abstract][Full Text] [Related]
2. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Kim TD; Shin S; Berry WL; Oh S; Janknecht R
J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
[TBL] [Abstract][Full Text] [Related]
3. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
Mallette FA; Richard S
Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
[TBL] [Abstract][Full Text] [Related]
4. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
Kogure M; Takawa M; Cho HS; Toyokawa G; Hayashi K; Tsunoda T; Kobayashi T; Daigo Y; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
Cancer Lett; 2013 Aug; 336(1):76-84. PubMed ID: 23603248
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
7. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.
Zhu J; Sen S; Wei C; Frazier ML
Int J Oncol; 2010 Jan; 36(1):39-48. PubMed ID: 19956831
[TBL] [Abstract][Full Text] [Related]
9. Expression of JMJD2A in infiltrating duct carcinoma was markedly higher than fibroadenoma, and associated with expression of ARHI, p53 and ER in infiltrating duct carcinoma.
Li BX; Li J; Luo CL; Zhang MC; Li H; Li LL; Xu HF; Shen YW; Xue AM; Zhao ZQ
Indian J Exp Biol; 2013 Mar; 51(3):208-17. PubMed ID: 23678541
[TBL] [Abstract][Full Text] [Related]
10. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
13. JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3.
Li L; Gao P; Li Y; Shen Y; Xie J; Sun D; Xue A; Zhao Z; Xu Z; Zhang M; Li B; Jiang J
Breast Cancer Res Treat; 2014 Oct; 147(3):487-500. PubMed ID: 25193278
[TBL] [Abstract][Full Text] [Related]
14. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
15. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
19. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
[TBL] [Abstract][Full Text] [Related]
20. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
Kim Y; Kim H; Jang SW; Ko J
Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
